LYNNE H BRUM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LYNNE H BRUM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LYNNE H BRUM. LYNNE H BRUM is VP, Corp. Comm.&Financial Plan in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and VP, Strategic Communications in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and VP Marketing and Corp Comm in METABOLIX, INC. ($MBLX) and VP Planning & Comms in METABOLIX, INC. ($MBLX).
Latest Insider Trading Transactions of LYNNE H BRUM
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Grant | A | 16.03 | 2,092 | 33,535 | 4,998 | 2.9 K to 5 K (+71.99 %) |
Mar 03 2021 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Grant | A | 16.03 | 2,092 | 33,535 | 4,998 | 2.9 K to 5 K (+71.99 %) |
Feb 16 2021 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Payment of Exercise | F | 22.77 | 693 | 15,780 | 2,906 | 3.6 K to 2.9 K (-19.26 %) |
Jan 27 2021 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Option Exercise | A | 16.49 | 11,500 | 189,635 | 11,500 | |
Aug 13 2020 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Payment of Exercise | F | 6.55 | 587 | 3,845 | 3,599 | 4.2 K to 3.6 K (-14.02 %) |
May 29 2020 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Option Exercise | A | 5.86 | 21,000 | 123,060 | 21,000 | |
May 23 2019 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Option Exercise | A | 0.90 | 60,000 | 54,000 | 60,000 | |
Apr 03 2019 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Payment of Exercise | F | 1.16 | 679 | 788 | 7,469 | 8.1 K to 7.5 K (-8.33 %) |
May 25 2018 | MBLX | YIELD10 BIOSCIENCE ... | BRUM LYNNE H | VP Planning & Comms | Option Exercise | A | 1.65 | 100,000 | 165,000 | 100,000 | |
Oct 28 2016 | MBLX | METABOLIX, INC. | BRUM LYNNE H | VP Planning & Comms | Option Exercise | A | 0.53 | 500,000 | 265,000 | 500,000 | |
Apr 05 2016 | MBLX | METABOLIX, INC. | BRUM LYNNE H | VP Marketing and Co ... | Payment of Exercise | F | 1.86 | 10,104 | 18,793 | 96,866 | 107 K to 96.9 K (-9.45 %) |
Jun 23 2015 | MBLX | METABOLIX, INC. | BRUM LYNNE H | VP Marketing and Co ... | Option Exercise | P | 3.98 | 13,113 | 52,190 | 13,113 | |
Jun 23 2015 | MBLX | METABOLIX, INC. | BRUM LYNNE H | VP Marketing and Co ... | Buy | P | 3.32 | 14,570 | 48,372 | 16,236 | 1.7 K to 16.2 K (+874.55 %) |
Apr 03 2015 | MBLX | METABOLIX, INC. | BRUM LYNNE H | VP Marketing and Co ... | Grant | A | 0.00 | 470,000 | 0 | 554,405 | 84.4 K to 554.4 K (+556.84 %) |
Apr 03 2015 | MBLX | METABOLIX, INC. | BRUM LYNNE H | VP Marketing and Co ... | Grant | A | 0.00 | 74,405 | 0 | 84,405 | 10 K to 84.4 K (+744.05 %) |
May 09 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 13.67 | 1,250 | 17,088 | 277,933 | |
May 09 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 279,183 | |
May 09 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 36.57 | 1,250 | 45,713 | 46,199 | 47.4 K to 46.2 K (-2.63 %) |
May 09 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 13.67 | 1,250 | 17,088 | 47,449 | 46.2 K to 47.4 K (+2.71 %) |
May 09 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 36.57 | 1,000 | 36,570 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
May 09 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
May 02 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 13.67 | 1,250 | 17,088 | 280,183 | |
May 02 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 281,433 | |
May 02 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 35.77 | 1,250 | 44,713 | 46,199 | 47.4 K to 46.2 K (-2.63 %) |
May 02 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 13.67 | 1,250 | 17,088 | 47,449 | 46.2 K to 47.4 K (+2.71 %) |
May 02 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 35.77 | 1,000 | 35,770 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
May 02 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
Apr 18 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 283,433 | |
Apr 18 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 35.79 | 1,000 | 35,790 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
Apr 18 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 282,433 | |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 38.33 | 1,000 | 38,330 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
Apr 25 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
Apr 11 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 284,433 | |
Apr 11 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 33.92 | 1,000 | 33,920 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
Apr 11 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
Apr 04 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 285,433 | |
Apr 04 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 35.98 | 1,000 | 35,980 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
Apr 04 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
Mar 28 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 286,433 | |
Mar 28 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 35.87 | 1,000 | 35,870 | 46,199 | 47.2 K to 46.2 K (-2.12 %) |
Mar 28 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 47,199 | 46.2 K to 47.2 K (+2.16 %) |
Mar 27 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 36.56 | 1,988 | 72,681 | 46,199 | 48.2 K to 46.2 K (-4.13 %) |
Mar 21 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 287,433 | |
Mar 21 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 40.12 | 400 | 16,048 | 48,187 | 48.6 K to 48.2 K (-0.82 %) |
Mar 21 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 40.12 | 1,000 | 40,120 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Mar 21 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Mar 14 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 288,433 | |
Mar 14 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 37.23 | 1,000 | 37,230 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Mar 14 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Mar 07 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 289,433 | |
Mar 07 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 43.94 | 1,000 | 43,940 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Mar 07 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Feb 28 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 290,433 | |
Feb 28 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 43.87 | 1,000 | 43,870 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Feb 28 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Feb 22 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 291,433 | |
Feb 22 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 37.13 | 1,000 | 37,130 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Feb 22 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Feb 14 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 292,433 | |
Feb 14 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 34.96 | 1,000 | 34,960 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Feb 14 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Feb 07 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 293,433 | |
Feb 07 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 34.33 | 1,000 | 34,330 | 48,587 | 49.6 K to 48.6 K (-2.02 %) |
Feb 07 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 49,587 | 48.6 K to 49.6 K (+2.06 %) |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 35.64 | 14,066 | 501,312 | 294,433 | |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Grant | A | 0.01 | 3,240 | 32 | 48,587 | 45.3 K to 48.6 K (+7.14 %) |
Feb 01 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 280,367 | |
Feb 01 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 35.29 | 1,000 | 35,290 | 44,196 | 45.2 K to 44.2 K (-2.21 %) |
Feb 01 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 45,196 | 44.2 K to 45.2 K (+2.26 %) |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 281,367 | |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Sell | S | 33.63 | 1,000 | 33,630 | 44,196 | 45.2 K to 44.2 K (-2.21 %) |
Jan 24 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Strategic Commu ... | Buy | M | 15.56 | 1,000 | 15,560 | 45,196 | 44.2 K to 45.2 K (+2.26 %) |
Jan 18 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Option Exercise | A | 15.56 | 1,000 | 15,560 | 282,367 | |
Jan 18 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Sell | S | 33.62 | 1,000 | 33,620 | 44,196 | 45.2 K to 44.2 K (-2.21 %) |
Jan 18 2006 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Buy | M | 15.56 | 1,000 | 15,560 | 45,196 | 44.2 K to 45.2 K (+2.26 %) |
Dec 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Option Exercise | A | 9.50 | 2,000 | 19,000 | 283,367 | |
Dec 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Sell | S | 24.80 | 2,000 | 49,600 | 44,196 | 46.2 K to 44.2 K (-4.33 %) |
Dec 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Buy | M | 9.50 | 2,000 | 19,000 | 46,196 | 44.2 K to 46.2 K (+4.53 %) |
Jul 22 2005 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Option Exercise | A | 17.16 | 10,230 | 175,547 | 285,367 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Option Exercise | A | 10.41 | 10,313 | 107,358 | 275,137 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Grant | A | 0.01 | 2,375 | 24 | 44,196 | 41.8 K to 44.2 K (+5.68 %) |
Oct 12 2004 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Option Exercise | A | 11.27 | 7,500 | 84,525 | 264,824 | |
May 10 2004 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Grant | A | 0.01 | 35,000 | 350 | 41,821 | 6.8 K to 41.8 K (+513.12 %) |
Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Option Exercise | A | 9.69 | 6,000 | 58,140 | 257,324 | |
Mar 19 2004 | VRTX | VERTEX PHARMACEUTI ... | BRUM LYNNE H | VP, Corp. Comm.&Fin ... | Grant | A | 0.01 | 800 | 8 | 6,821 | 6 K to 6.8 K (+13.29 %) |
Page: 1